India's Gland Pharma (GLAD.NS) reported a bigger-than-expected first-quarter profit on Monday, boosted by strong sales in its key European and U.S. markets.
The Hyderabad-based company reported a consolidated net profit of 3.17 billion rupees ($33.3 million) for the quarter ended June 30, from 2.15 billion rupees a year earlier.
That also beat analysts' average estimate of 2.89 billion rupees, per data compiled by LSEG.
Here are some more details:
($1 = 95.3000 Indian rupees)
